Spots Global Cancer Trial Database for Comparative Pharmacokinetics of a Compounded 6-mercaptopurine Liquid Formulation Preparation and Tablets
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Comparative Pharmacokinetics of a Compounded 6-mercaptopurine Liquid Formulation Preparation and Tablets
Official Title: Comparative Pharmacokinetics of a Compounded 6-mercaptopurine Liquid Formulation Preparation and Tablets
Study ID: NCT01324336
Conditions
Interventions
Study Description
Brief Summary: The purpose of this study is to compare the pharmacokinetics of a routinely used compounded liquid formulation of 6-mercaptopurine (6-MP) with commercially available tablets in patients who are receiving treatment with 6-MP as part of their clinical treatment for acute lymphoblastic leukemia (ALL).
Detailed Description:
Eligibility
Minimum Age: 4 Years
Eligible Ages: CHILD
Sex: ALL
Healthy Volunteers: No
Locations
The Children's Mercy Hospital, Kansas City, Missouri, United States
Contact Details
Name: Kathleen A Neville, MD, MS
Affiliation: The Children's Mercy Hospitals and Clinics
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
